UNSPSC 51162316: Acetaminophen/chlorpheniramine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162316 Acetaminophen/chlorpheniramine/pseudoephedrine is a Commodity code that in recent state and local procurement does not appear to align with the work actually being bought. The two recent opportunities tagged under this code—the Washington State Department of Corrections' parenteral products and services solicitation, and Seminole County, Florida's naloxone and drug deactivation systems procurement—involve injectable and emergency pharmaceutical products rather than the combination cold-and-allergy oral medication the code nominally describes. The parenteral products solicitation encompasses intravenous nutrition solutions, IV fluids, and injectable controlled substances for correctional healthcare, while the naloxone procurement targets opioid-reversal agents and drug disposal equipment. Neither opportunity reflects the specific drug combination named in the code.

The mismatch suggests the code shows little relevant recent activity for acetaminophen/chlorpheniramine/pseudoephedrine as a distinct commodity. When state and local buyers do procure cold-and-allergy combination products, they appear not to tag them under this Commodity code, or recent opportunities in this category are absent from available sources. The Washington opportunity issued by the Department of Corrections does reflect meaningful state procurement volume—parenteral products for eight correctional facilities across three regions, with anticipated awards to up to three contractors per region and a contract term through June 30, 2030—but falls outside the code's nominal scope. Bid response was due October 7, 2026. The Seminole County opportunity for naloxone and deactivation systems represents annual procurement of 1,900 units and 800 units respectively through quarterly deliveries, though that opportunity's posted due date of July 26, 2023 places it outside the current active window.